Need Presentation In 10 Hours: 7-10 Slides Answer

I Need Presentation In Maximum 10 Hour In 7 10 Slides Answering All

Research a specific pathogen involved in causing a sexually transmitted disease. Present a case study of a patient with this disease, including patient details, signs and symptoms, reasons for seeking treatment, diagnostic steps (such as smears, Gram stain, cultures), the prescribed treatment, and current statistics on this STD. Include at least 2 scientific references in correct APA format. Prepare a presentation of 7-10 slides addressing all these points, with the goal of completing it within 10 hours.

Paper For Above instruction

Introduction

Sexually transmitted infections (STIs) pose a significant public health challenge worldwide. Among these, Chlamydia trachomatis is one of the most common bacterial pathogens responsible for sexually transmitted diseases. This presentation explores a case study of a patient diagnosed with chlamydial infection, detailing diagnostic procedures, treatment, and current epidemiological statistics.

Pathogen Overview

Chlamydia trachomatis is a gram-negative bacterium that infects mucous membranes of the reproductive tract (World Health Organization, 2019). It is responsible for the most prevalent bacterial STI globally, particularly affecting young women and men who are sexually active. The pathogen is transmitted primarily through sexual contact, including vaginal, anal, and oral sex. The infection can often be asymptomatic but may lead to serious complications such as pelvic inflammatory disease (PID), infertility, and ectopic pregnancies if left untreated (Chao et al., 2020).

Case Study of Patient

The patient is a 24-year-old female who presented to the STD clinic with complaints of abnormal vaginal discharge and dysuria (painful urination). She reported unprotected sexual activity with a new partner two weeks prior to her visit. She also experienced mild lower abdominal discomfort but did not have any fever or pelvic pain. The patient sought treatment due to concerns about her symptoms and possible STI exposure.

Signs and Symptoms

On examination, the patient exhibited mucopurulent vaginal discharge, erythema of the cervix, and tenderness upon cervical motion, suggestive of cervicitis. She reported no pelvic or systemic symptoms such as fever, chills, or nausea. These signs prompted further diagnostic evaluation for STI pathogens.

Diagnostic Approach

The clinician employed several diagnostic steps to identify the causative agent:

• Vaginal swab and microscopy: A Gram stain of cervical smear revealed intracellular gram-negative bacteria consistent with Chlamydia trachomatis.
• Culture: A nucleic acid amplification test (NAAT) was performed on the specimen, which is highly sensitive and specific for chlamydial detection (George et al., 2018).
• Expected results: The Gram stain may show typical eosinophilic inclusion bodies, although cultures are less commonly used now due to NAAT's superior sensitivity.

Treatment Prescribed

The patient was prescribed a single oral dose of Azithromycin 1 gram, which is recommended as first-line treatment for uncomplicated chlamydial infections (CDC, 2021). She was also advised to avoid sexual contact until completing treatment and recommended to notify her sexual partners. Follow-up testing was scheduled to confirm cure if symptoms persisted or at appropriate intervals.

Current Statistics

Recent epidemiological data indicate that Chlamydia trachomatis remains highly prevalent among sexually active young people. According to the CDC (2022), approximately 1.8 million cases were reported in the United States alone in 2021, with many cases going undiagnosed due to asymptomatic nature. The infection is more common among women aged 15-24, emphasizing the importance of routine screening in this demographic to prevent long-term complications.

Conclusion

Chlamydia trachomatis is a prevalent and often silent STI that can lead to significant reproductive health issues if untreated. Early diagnosis through appropriate testing like NAAT and prompt antibiotic treatment are crucial for effective management and prevention of transmission. Public health efforts should continue emphasizing screening, education, and safe sexual practices to combat this infection.

References

• Centers for Disease Control and Prevention. (2021). Sexually transmitted infections treatment guidelines, 2021. https://www.cdc.gov/std/tg2021/default.htm
• George, S. P., et al. (2018). Diagnostic methods for Chlamydia trachomatis infection. Clinical Microbiology Reviews, 31(2). https://doi.org/10.1128/CMR.00005-17
• World Health Organization. (2019). Report on sexually transmitted infections. https://www.who.int/publications/i/item/9789241565727
• Chao, S., et al. (2020). Clinical manifestations and diagnosis of chlamydial infections. Infection and Drug Resistance, 13, 993–1003. https://doi.org/10.2147/IDR.S250679
• Canadian Journal of Infectious Diseases & Medical Microbiology. (2019). Advances in STI diagnostics. https://doi.org/10.1155/2019/2476581
• World Health Organization. (2022). Global health sector response to sexually transmitted infections. https://www.who.int/publications/i/item/9789240059678
• Haggerty, C. L., et al. (2019). Pelvic inflammatory disease: from diagnosis to treatment. Clinical Microbiology Reviews, 32(1). https://doi.org/10.1128/CMR.00058-18
• Marrazzo, J. M., et al. (2021). Prevention and control of STIs. JAMA, 326(4), 317–318. https://doi.org/10.1001/jama.2021.9277
• Jewkes, R., & Morrell, R. (2018). Gender and sexual health: policy and practice. BioMed Central Public Health, 18(1), 1022. https://doi.org/10.1186/s12889-018-5931-5
• Shaw, J. L., et al. (2017). The role of screening in controlling chlamydia infections. American Journal of Preventive Medicine, 52(4), S88–S96. https://doi.org/10.1016/j.amepre.2016.12.014